Maynard Um
-
-
-
-
-
-
-
Citius Oncology deploys AI platform ahead of LYMPHIR launch
-
-
-
-
-
-
-
Citius Pharmaceuticals (CTXR) Misses Q2 EPS by 11c
-
-
-
-
-
-
-
Citius Pharmaceuticals (CTXR) Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok Program and Pathway to Approval
-
-
-
-
-
-
-
Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)
-
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

